FrancophonIA/ELRC3.0 huggingface dataset:
English: Population pharmacokinetic analyses did not detect any effect of methotrexate, NSAIDs, and corticosteroids on abatacept clearance (see section 5.2).
Croatian: Analiza populacijske farmakokinetike nije otkrila učinke metotreksata, NSAIL-a ni kortikosteroida na klirens abatacepta (vidjeti dio 5.2).
English: Do not use this medicine after the expiry date which is stated on the label and the carton after EXP.
Croatian: Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na naljepnici i kutiji iza oznake "EXP"/“Rok valjanosti“.
English: RA is usually a chronic (long-term), progressive disease.
Croatian: Reumatoidni artritis je obično kronična (dugotrajna), progresivna bolest.
English: Of the 190 patients with pJIA treated with intravenous ORENCIA, one (0.5%) patient discontinued due to non-consecutive infusion reactions, consisting of bronchospasm and urticaria.
Croatian: Od 190 bolesnika s pJIA-om liječenih lijekom ORENCIA za intravensku primjenu, jedan (0,5%) je bolesnik prekinuo liječenje zbog neuzastopnih infuzijskih reakcija koje su se sastojale od bronhospazma i urtikarije.
English: In study SC-II, structural joint damage was assessed radiographically and expressed as a change from baseline in the van der Heijde-modified Total Sharp Score (mTSS) and its components.
Croatian: U ispitivanju SC-II, strukturno oštećenje zglobova ocijenjeno je radiografski i izraženo kao promjena ukupne ocjene na po van der Heijdeu modificiranoj Sharpovoj bodovnoj skali (engl. modified Total Sharp Score, mTSS) i njezinim komponentama u odnosu na početnu vrijednost.
English: No clinical impact of these antibody responses was detected, and no safety concerns were observed upon reinitiation of abatacept therapy.
Croatian: Nije primijećen klinički utjecaj tih odgovora protutijela te nisu opaženi nikakvi sigurnosni problemi nakon ponovnog uvođenja liječenja abataceptom.
English: Reversible pharmacological effects consisted of minimal transient decreases in serum IgG and minimal to severe lymphoid depletion of germinal centres in the spleen and/or lymph nodes.
Croatian: Reverzibilni farmakološki učinci obuhvaćali su minimalno prolazno sniženje razine IgG-a u serumu te minimalnu do tešku limfoidnu depleciju germinativnih centara u slezeni i/ili limfnim čvorovima.
English: Of the 219 patients entering the study, 56 (25.6%) had previously been treated with biologic DMARD therapy (including TNF inhibitors and tocilizumab).
Croatian: Od 219 bolesnika uključenih u ispitivanje, njih 56 (25,6%) prethodno je bilo liječeno biološkim DMARD-ima (uključujući TNF-inhibitore i tocilizumab).
English: Dates of ORENCIA Treatment:
Croatian: Datumi primjene lijeka ORENCIA:
English: In study IV, there were 37 patients with COPD treated with intravenous abatacept and 17 treated with placebo.
Croatian: U ispitivanju IV bilo je 37 bolesnika s KOPB-om koji su bili liječeni intravenski primijenjenim abataceptom i 17 onih koji su primali placebo.
English: Before you start - some Do's and Don'ts Do
Croatian: Prije nego što počnete - što svakako morate, a što nikako ne smijete činiti Svakako morate
English: Do not use if your pre-filled syringe does not have the correct amount of liquid.
Croatian: Nemojte upotrijebiti napunjenu štrcaljku ako ne sadrži odgovarajuću količinu tekućine.
English: Because there is a higher incidence of infections and malignancies in the elderly in general, caution should be used when treating the elderly (see section 4.8).
Croatian: S obzirom da je u starijih osoba općenito povećana incidencija infekcija i zloćudnih bolesti, potreban je oprez u liječenju starijih bolesnika (vidjeti dio 4.8).
English: Check that the expiry date and batch number match the ones on the carton.
Croatian: Provjerite da datum isteka roka valjanosti i broj serije na štrcaljki odgovaraju onima na kutiji.
English: PREPARE FOR INJECTION
Croatian: 2. PRIPREMITE SE ZA INJEKCIJU
English: The geometric mean estimate (90% confidence interval) for the bioavailability of abatacept following subcutaneous administration relative to intravenous administration is 78.6% (64.7%, 95.6%).
Croatian: Procijenjena geometrijska sredina (90%-tni interval pouzdanosti) za bioraspoloživost abatacepta nakon supkutane primjene u odnosu na intravensku primjenu iznosi 78,6% (64,7%; 95,6%).
English: Acute infusion-related events (adverse reactions occurring within 1 hour of the start of the infusion) in seven pooled intravenous studies (for studies II, III, IV and V see section 5.1) were more common in the abatacept-treated patients than the placebo-treated patients (5.2% for abatacept, 3.7% for placebo).
Croatian: Akutne reakcije vezane uz infuziju (nuspojave koje su nastupile u roku od 1 sat od početka infuzije) u sedam objedinjenih ispitivanja intravenske primjene (za ispitivanja II, III, IV i V vidjeti dio 5.1) bile su češće u bolesnika liječenih abataceptom nego u bolesnika koji su primali placebo (5,2% za abatacept, 3,7% za placebo).
English: Overall, 6.9% (15/218) of subjects (cohorts combined) had a positive immunogenicity response relative to baseline during the cumulative period, including the 4-month short-term treatment period, 20-month extension treatment period and the 6-month post abatacept follow-up period.
Croatian: Sveukupno, 6,9% (15/218) ispitanika (kohorte u kombinaciji) imalo je pozitivan odgovor na imunogenost u odnosu na početnu vrijednost tijekom kumulativnog razdoblja, uključujući 4-mjesečno razdoblje kratkoročnog liječenja, 20-mjesečni razdoblje nastavka liječenja i 6-mjesečno razdoblje praćenja nakon abatacepta.
English: In this case, you will get training on how to inject ORENCIA yourself.
Croatian: U tom slučaju će Vas naučiti kako da si sami date injekciju.
English: No difference in clinical response between subcutaneous and intravenous abatacept was seen across the 3 weight groups.
Croatian: Nisu opažene razlike u kliničkom odgovoru između supkutane i intravenske primjene abatacepta u tri skupine prema tjelesnoj težini.
English: Start of ORENCIA Treatment:
Croatian: Početak primjene lijeka ORENCIA:
English: However, if you are feeling tired or unwell after receiving ORENCIA, you should not drive or operate any machinery.
Croatian: Međutim, ako se osjećate umorno ili loše nakon što ste primili lijek ORENCIA, ne smijete voziti niti rukovati bilo kakvim strojevima.
English: The results from studies II, III, and VI are shown in Table 7.
Croatian: Rezultati iz ispitivanja II, III i VI prikazani su u Tablici 7.
English: There may be a small air bubble in the liquid in the syringe.
Croatian: U tekućini u štrcaljki možda će se nalaziti maleni mjehurić zraka.
English: When receiving ORENCIA, patients that require blood glucose monitoring should be advised to consider methods that do not react with maltose, such as those based on glucose dehydrogenase nicotine adenine dinucleotide (GDH-NAD), glucose oxidase, or glucose hexokinase test methods.
Croatian: Kada primaju lijek ORENCIA, bolesnicima koji moraju mjeriti šećer u krvi treba savjetovati da koriste testove koji ne reagiraju s maltozom, poput onih koji se temelje na metodama glukoza dehidrogenaza nikotin adenin dinukleotid (GDH-NAD), glukoza oksidaza ili glukoza heksokinaza.
English: Three patients had SAEs (postoperative wound infection, H1N1 influenza, and myocardial ischemia in 1 patient each) that were not considered related to the study drug.
Croatian: U tri su se bolesnika pojavile ozbiljne nuspojave (infekcija rane nakon operacije, gripa uzrokovana virusom H1N1 i ishemija miokarda - svaka u po 1 bolesnika) koje se nisu smatrale povezanima s ispitivanim lijekom.
English: During the first 4-month open-label period, the overall safety profile in these 409 pJIA patients was similar to that observed in the RA population with the following exceptions in the pJIA patients:
Croatian: Tijekom prvog 4-mjesečnog otvorenog razdoblja ukupan sigurnosni profil u tih 409 bolesnika s pJIA-om bio je sličan onome opaženome u populaciji s reumatoidnim artritisom, uz sljedeće izuzetke u bolesnika s pJIA-om:
English: Allergic reactions have been reported uncommonly with abatacept administration in clinical trials, where patients were not required to be pretreated to prevent allergic reactions (see section 4.8).
Croatian: Alergijske reakcije prijavljene su manje često kod primjene abatacepta u kliničkim ispitivanjima kada se nije zahtijevalo prethodno liječenje radi sprečavanja alergijskih reakcija (vidjeti dio 4.8).
English: Keep any remaining unused syringes in their original carton, in the refrigerator.
Croatian: Preostale neupotrebljene štrcaljke ostavite u hladnjaku u originalnoj kutiji.
English: Abatacept Abatacept Placebo Abatacept group in Period B
Croatian: Abatacept Placebo Abatacept skupina u
English: PUSH DOWN on skin
Croatian: PRITISNITE na kožu
English: If you forget to receive ORENCIA
Croatian: Ako ste zaboravili primiti lijek ORENCIA
English: b Concurrent DMARDs included one or more of the following: methotrexate, chloroquine/hydroxychloroquine, sulfasalazine,
Croatian: b Istodobno primijenjeni DMARD-i uključuju jedan ili više od sljedećih: metotreksat, klorokin/hidroklorokin, sulfasalazin,
English: ORENCIA contains the active substance abatacept, a protein produced in cell cultures.
Croatian: ORENCIA sadrži djelatnu tvar abatacept, bjelančevinu proizvedenu na staničnim kulturama.
English: The primary outcome was the mean change in disease activity in abatacept-treated patients compared to placebo-treated patients at 6 months with a subsequent double-blind assessment of safety and efficacy of abatacept and infliximab at 12 months.
Croatian: Primarna mjera ishoda bila je prosječna vrijednost promjene bolesti u bolesnika liječenih abataceptom u usporedbi s bolesnicima koji su primali placebo nakon 6 mjeseci, s naknadnom dvostruko slijepom ocjenom sigurnosti i djelotvornosti abatacepta i infliksimaba nakon 12 mjeseci.
English: Study V: abatacept or infliximab versus placebo
Croatian: Ispitivanje V: abatacept ili infliksimab naspram placeba
English: In study SC-I, abatacept was given subcutaneously to patients after a single loading dose of intravenous abatacept and then every week thereafter.
Croatian: U ispitivanju SC-I abatacept je bolesnicima primijenjen supkutano nakon jedne udarne intravenske doze abatacepta, a nakon toga svakog tjedna.
English: The absence of concomitant methotrexate (MTX) did not appear to be associated with a higher rate of seropositivity in Period B placebo recipients.
Croatian: Izostanak istodobne primjene metotreksata (MTX) nije bio povezan s većim udjelom seropozitivnosti u bolesnika koji su u Razdoblju B primali placebo.
English: Data were analysed in an as-observed analysis using mean change in total score from the previous annual visit.
Croatian: Podaci su analizirani "prema opaženome" (engl. "as-observed" analysis), na temelju prosječne vrijednosti promjene u ukupnom rezultatu od prethodne godišnje kontrole.
English: Examine the ClickJect Pre-filled Pen:
Croatian: Pregledajte napunjenu brizgalicu ClickJect:
English: The Marketing Authorisation Holder (MAH) shall ensure that in each Member State where ORENCIA is marketed, all patients who are expected to use ORENCIA have access to the Patient Alert Card (provided within each medicine pack).
Croatian: Nositelj odobrenja za stavljanje lijeka u promet osigurat će u svakoj državi članici u kojoj je ORENCIA stavljena u promet dostupnost Karici sa upozorenjima za bolesnika (priloženu unutar svakog pojedinačnog pakiranja lijeka) za sve bolesnike za koje se predviđa da će se liječiti lijekom ORENCIA.
English: The relevance of these findings to the clinical use of abatacept is unknown.
Croatian: Nije poznat značaj ovih nalaza za kliničku primjenu abatacepta.
English: If neurological symptoms suggestive of PML occur during ORENCIA therapy, treatment with ORENCIA should be discontinued and appropriate diagnostic measures initiated.
Croatian: Pojave li se tijekom terapije lijekom ORENCIA neurološki simptomi koji upućuju na PML, treba prekinuti primjenu lijeka ORENCIA i započeti odgovarajuće dijagnostičke postupke.
English: Study IV primarily assessed safety in patients with active rheumatoid arthritis requiring additional intervention in spite of current therapy with non-biological and/or biological DMARDs; all DMARDs used at enrollment were continued.
Croatian: Ispitivanje IV prvenstveno je ocjenjivalo sigurnost u bolesnika s aktivnim reumatoidnim artritisom kojima je bila potrebna dodatna intervencija usprkos postojećoj terapiji nebiološkim i/ili biološkim DMARD-ima, a bolesnici su nastavili uzimati sve DMARD-e koje su koristili u trenutku uključivanja u ispitivanje.
English: No dose adjustment is required when used in combination with other DMARDs, corticosteroids, salicylates, nonsteroidal anti-inflammatory drugs (NSAIDs), or analgesics.
Croatian: Nije potrebno prilagođavati dozu kada se ovaj lijek koristi u kombinaciji s drugim DMARD-ima, kortikosteroidima, salicilatima, nesteroidnim protuupalnim lijekovima (NSAIL) ili analgeticima.
English: Proportion (%) of polyarticular JIA patients with ACR responses or inactive disease
Croatian: Udio (%) bolesnika s poliartikularnim JIA-om s ACR odgovorom ili neaktivnom bolešću
English: During Periods A, B, and C, acute infusion-related reactions occurred at a frequency of 4%, 2%, and 4%, respectively, and were consistent with the types of reactions reported in adults.
Croatian: Učestalost akutnih reakcija vezanih uz infuziju iznosila je 4% tijekom Razdoblja A, 2% tijekom Razdoblja B te 4% tijekom Razdoblja C i bila je u skladu s vrstama reakcija prijavljenima u odraslih.
English: In vitro, abatacept attenuates human T lymphocyte activation as measured by decreased proliferation and cytokine production.
Croatian: Abatacept in vitro umanjuje aktivaciju ljudskih T-limfocita, što je izraženo smanjenjem proliferacije i stvaranja citokina.
English: The Pen automatically delivers the medicine.
Croatian: Brizgalica automatski injicira lijek.
English: If you have received ORENCIA while you were pregnant, it is important that you inform the baby's health care personnel before any vaccinations are given to your baby.
Croatian: Ako ste primali lijek ORENCIA tijekom trudnoće, važno je da o tome obavijestite zdravstveno osoblje koje skrbi za Vaše dijete prije nego što mu oni daju bilo koje cjepivo.
English: Check the expiry date printed on the label.
Croatian: Provjerite rok valjanosti otisnut na naljepnici.
English: Anti-abatacept antibodies were generally transient and of low titer.
Croatian: Antitijela na abatacept obično su bila prolazna i niskog titra.
English: Don't use the syringe if there are visible signs of needle damage or bending.
Croatian: Nemojte upotrijebiti štrcaljku ako postoje vidljivi znakovi oštećenja ili savijanja igle.
English: The recommended dose of abatacept for adults with rheumatoid arthritis or psoriatic arthritis is based on body weight:
Croatian: Preporučena doza abatacepta za odrasle osobe s reumatoidnim artritisom ili psorijatičnim artritisom temelji se na tjelesnoj težini:
English: Parenteral medicinal products containing maltose can interfere with the readings of blood glucose monitors that use test strips with glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ).
Croatian: Parenteralni lijekovi koji sadrže maltozu mogu utjecati na rezultate na mjeračima glukoze u krvi koji koriste test trake s glukoza dehidrogenaza pirolokinolinkinonom (GDH-PQQ).
English: After multiple intravenous infusions (days 1, 15, 30, and every 4 weeks thereafter), the pharmacokinetics of abatacept in rheumatoid arthritis patients showed dose-proportional increases of Cmax and AUC over the dose range of 2 mg/kg to 10 mg/kg.
Croatian: Nakon višekratnih intravenskih infuzija (1., 15. i 30. dana te svaka 4 tjedna nakon toga), farmakokinetika abatacepta u bolesnika s reumatoidnim artritisom pokazala je dozi sukladno povećanje Cmax i AUC-a u rasponu doza od 2 mg/kg do 10 mg/kg.
English: Once you remove it from your skin, the transparent tip will lock over the needle.
Croatian: Nakon što uklonite brizgalicu s kože, prozirni vrh će zatvoriti iglu.
English: The increased incidence of lymphomas and mammary tumours observed in mice treated with abatacept may have been associated with decreased control of murine leukaemia virus and mouse mammary tumour virus, respectively, in the presence of long-term immunomodulation.
Croatian: Povećana incidencija limfoma i tumora mliječne žlijezde opažena u miševa kojima je primijenjen abatacept možda je bila povezana sa smanjenom kontrolom virusa mišje leukemije i virusa mišjeg tumora mliječne žlijezde zbog dugotrajne imunomodulacije.
English: Infections were the most commonly reported adverse events in patients with pJIA.
Croatian: Infekcije su bile najčešće prijavljen štetni događaj u bolesnika s pJIA-om.
English: From a microbiological point of view, the reconstituted solution should be diluted immediately.
Croatian: S mikrobiološkog stajališta, rekonstituiranu otopinu treba odmah razrijediti.
English: Abatacept 125 mg SC N=213
Croatian: Abatacept 125 mg s.c. N=213
English: Don't press on the plunger head until you begin your injection.
Croatian: Nemojte pritiskati glavu klipa dok ne započnete s injiciranjem.
English: The progression of structural damage was lower in patients receiving continuous abatacept plus methotrexate treatment (for 24 months) compared to patients who initially received methotrexate plus placebo (for 12 months) and were switched to abatacept plus methotrexate for the next 12 months.
Croatian: Progresija strukturnih oštećenja bila je manja u bolesnika koji su kontinuirano primali abatacept i metotreksat (tijekom 24 mjeseca) u usporedbi s bolesnicima koji su najprije primali metotreksat i placebo (tijekom 12 mjeseci) te su prebačeni na liječenje abataceptom i metotreksatom sljedećih 12 mjeseci.
English: Antibodies directed against the abatacept molecule were assessed by ELISA assays in 3,985 rheumatoid arthritis patients treated for up to 8 years with abatacept.
Croatian: Postojanje antitijela usmjerenih protiv molekule abatacepta ispitano je ELISA testovima u 3985 bolesnika s reumatoidnim artritisom liječenih abataceptom najdulje 8 godina.
English: Long-term safety data in 2 to 5 year age cohort with pJIA was limited, but the existing evidence did not reveal any new safety concern in this younger paediatric population.
Croatian: Podaci o dugoročnoj sigurnosti prikupljeni u bolesnika s pJIA-om u kohorti ispitanika u dobi od 2 do 5 godina starosti bili su ograničeni, no postojeći dokazi nisu ukazali ni na kakve nove sigurnosne probleme u toj mlađoj pedijatrijskoj populaciji.
English: if you have had tuberculosis (TB) or have symptoms of tuberculosis (persistent cough, weight loss, listlessness, mild fever) tell your doctor.
Croatian: ako ste imali tuberkulozu (TBC) ili imate simptome tuberkuloze (uporan kašalj, gubitak tjelesne težine, bezvoljnost, blagu vrućicu), obavijestite o tome svog liječnika.
English: A. Check the expiry date and batch number on the carton The expiry date can be found on the ORENCIA carton and on each syringe.
Croatian: Provjerite datum isteka roka valjanosti i broj serije na kutiji Datum isteka roka valjanosti pronaći ćete na kutiji lijeka ORENCIA i na svakoj štrcaljki.
English: Health-related quality of life was assessed by the SF-36 questionnaire at 6 months in studies I, II, and III and at 12 months in studies I and II.
Croatian: Kvaliteta života vezana uz zdravlje ocijenjena je pomoću upitnika SF-36 nakon 6 mjeseci u ispitivanjima I, II i III te nakon 12 mjeseci u ispitivanjima
English: Study V continued for an additional 6 months with the abatacept and infliximab groups only.
Croatian: V nastavljeno je dodatnih 6 mjeseci samo sa skupinama koje su primale abatacept i infliksimab.
English: Other reactions potentially associated with hypersensitivity to the medicinal product, such as hypotension, urticaria, and dyspnea, that occurred within 24 hours of ORENCIA infusion, were uncommon.
Croatian: Ostale reakcije koje se mogu povezati s preosjetljivošću na lijek, kao što su hipotenzija, urtikarija i dispneja koje su nastupile unutar 24 sata od infuzije lijeka ORENCIA, bile su manje česte.
English: In study II, 43% of the patients who had not achieved an ACR 20 response at 6 months developed an ACR 20 response at 12 months.
Croatian: U ispitivanju II 43% bolesnika koji nisu postigli odgovor ACR20 nakon 6 mjeseci razvilo je odgovor ACR20 nakon 12 mjeseci.
English: Improvement in physical function in controlled trials Methotrexate-Naive Inadequate response to Methotrexate
Croatian: Poboljšanje fizičke funkcije u kontroliranim ispitivanjima Nisu primali metotreksat
English: Study II, III, IV, and VI patients were randomised to receive a fixed dose approximating 10 mg/kg of abatacept or placebo for 12 (studies II, IV, and VI) or 6 months (study III).
Croatian: U ispitivanjima II, III, IV i VI bolesnici su randomizirani da primaju fiksnu dozu od približno 10 mg/kg abatacepta ili placebo tijekom 12 (ispitivanja II, IV i VI) ili 6 mjeseci (ispitivanje III).
English: STEP 4: Dispose of the syringe and keep a record
Croatian: KORAK 4: Zbrinite štrcaljku i zabilježite
English: Flare was defined as: ≥ 30% worsening in at least 3 of the 6 pJIA core set variables ≥ 30% improvement in not more than 1 of the 6 pJIA core set variables ≥ 2 cm (possible up to 10 cm) of worsening must have been present if the Physician or Parent Global Assessment was used to define flare worsening in ≥ 2 joints must have been present if the number of active joints or joints with limited range of motion was used to define flare
Croatian: Razbuktavanje je definirano kao: ≥ 30%-tno pogoršanje najmanje 3 od 6 osnovnih varijabli pJIA-a ≥ 30%-tno poboljšanje najviše 1 od 6 osnovnih varijabli pJIA-a ako je za definiciju razbuktavanja korištena Globalna ocjena liječnika ili roditelja, moralo je biti prisutno pogoršanje ≥ 2 cm (moguće i do 10 cm) ako je za definiciju razbuktavanja korišten broj aktivnih zglobova ili zglobova ograničene pokretljivosti, moralo je biti prisutno pogoršanje u ≥ 2 zgloba
English: * n = 119 for Abatacept SC + MTX; n = 116 for MTX
Croatian: * n = 119 za abatacept za supkutanu primjenu + MTX; n = 116 za MTX
English: In the substudy 108 subjects were randomised 1:1 in double blinded fashion to receive abatacept at doses approximating 10 mg/kg (ABA 10) or 5 mg/kg (ABA 5).
Croatian: U tom je podispitivanju 108 ispitanika randomizirano na dvostruko slijepi način u omjeru 1:1 da primaju abatacept u dozama od približno 10 mg/kg (ABA 10) ili 5 mg/kg (ABA 5).
English: While transitioning from TNF-inhibitor therapy to ORENCIA therapy, patients should be monitored for signs of infection (see section 5.1, study VII).
Croatian: Kod prijelaza s terapije TNF-inhibitorom na lijek ORENCIA bolesnike treba nadzirati kako bi se uočili eventualni znakovi infekcije (vidjeti dio 5.1, ispitivanje VII).
English: Embryo-foetal development studies were conducted with abatacept in mice, rats, and rabbits at doses up to 20 to 30 times a human 10 mg/kg dose and no undesirable effects were observed in the offspring.
Croatian: Istraživanja embriofetalnog razvoja provedena su s abataceptom na miševima, štakorima i kunićima pri dozama do 20-30 puta većima od doze za ljude od 10 mg/kg te nisu opaženi neželjeni učinci na mladunčad.
English: Studies I, II, III, V, and VI required patients to have at least 12 tender and 10 swollen joints at randomisation.
Croatian: U ispitivanjima I, II, III, V i VI bolesnici su u trenutku randomizacije morali imati najmanje 12 bolnih i 10 otečenih zglobova.
English: Studies in vitro and in animal models demonstrate that abatacept modulates T lymphocyte-dependent antibody responses and inflammation.
Croatian: Istraživanja in vitro i na životinjskim modelima pokazuju da abatacept modulira o T-limfocitima ovisan odgovor antitijela te upalu.
English: The results from studies II, III, and VI are shown in Table 6.
Croatian: Rezultati iz ispitivanja II, III i VI prikazani su u Tablici 6.
English: Physical Function Response
Croatian: Odgovor fizičke funkcije